{
    "organizations": [],
    "uuid": "5ed140ad42ab92623c68438141d99db87ae50421",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-emerald-health-therapeutics-announ/brief-emerald-health-therapeutics-announces-16-8-mln-prospectus-sale-idUSFWN1SM107",
    "ord_in_thread": 0,
    "title": "BRIEF-Emerald Health Therapeutics Announces $16.8 Mln Prospectus Sale",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Emerald Health Therapeutics Inc:\n* EMERALD HEALTH THERAPEUTICS ANNOUNCES $16.8 MILLION PROSPECTUS SALE; CONCURRENT SECONDARY SALE\n* EMERALD HEALTH THERAPEUTICS INC - INVESTOR AGREED TO PURCHASE 4 MILLION UNITS AT PRICE OF $4.20 PER UNIT Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-15T20:09:00.000+03:00",
    "crawled": "2018-05-16T18:47:29.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "emerald",
        "health",
        "therapeutic",
        "inc",
        "emerald",
        "health",
        "therapeutic",
        "announces",
        "million",
        "prospectus",
        "sale",
        "concurrent",
        "secondary",
        "sale",
        "emerald",
        "health",
        "therapeutic",
        "inc",
        "investor",
        "agreed",
        "purchase",
        "million",
        "unit",
        "price",
        "per",
        "unit",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}